EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical usefulness of serum autotaxin levels for predicting decompensation development and prognosis in patients with compensated cirrhosis

Chisato Saeki iD, Tsunekazu Oikawa, Tomoya Kanai, Sachie Kiryu, Hiroshi Kamioka, Kaoru Ueda, Masanori Nakano, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota iD

PLOS One · 09.04.2026 · 21 (4) · e0347310

DOI: 10.1371/journal.pone.0347310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 09.04.2026. Verfasst von Chisato Saeki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Phosphoric Diester Hydrolases, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The progression from compensated to decompensated cirrhosis markedly worsens prognosis. This study investigated the clinical utility of serum autotaxin (ATX) levels as a predictive biomarker for decompensation and mortality, particularly in patients with compensated cirrhosis.

Methods

A total of 210 patients with cirrhosis (165 with compensated cirrhosis) were retrospectively analyzed and classified into three groups based on baseline serum ATX levels: low-, intermediate-, and high-ATX groups.

Results

Over a median follow-up of 51.6 months, 43 patients (20.5%) died of liver-related events, and 26 patients (15.8%) with compensated cirrhosis at baseline progressed to decompensation. In both the overall cohort and the compensated cirrhosis subgroup, the high-ATX group had significantly lower cumulative survival rates than the intermediate- and low-ATX groups ( p < 0.001 for both). Multivariate analysis identified high serum ATX levels as an independent predictor of mortality (overall cohort: hazard ratio [HR], 1.661; p = 0.039; compensated cirrhosis subgroup: HR, 7.488; p < 0.001). Furthermore, the cumulative incidence of decompensation was highest in the high-ATX group ( p < 0.001), and high serum ATX levels were independently associated with an increased risk of decompensation (HR, 5.502; p < 0.001).

Conclusion

ATX represents a promising non-invasive biomarker for predicting decompensation and poor prognosis in patients with compensated cirrhosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphoric Diester HydrolasesLiver CirrhosisHumansFemaleLysophospholipase DPrognosisBiomarkersMaleMiddle AgedRetrospective StudiesAgedDisease Progression

Substanzen

Phosphoric Diester HydrolasesLysophospholipase DBiomarkers

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Division of Gastroenterology, Department of Internal Medicine, Fuji City General Hospital, Fuji-shi, Shizuoka, Japan.
  • Project Research Units, Research Center for Medical Science, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

ORCID-Profile: Chisato Saeki, Akihito Tsubota

Zitieren

APA

Saeki, C., Oikawa, T., Kanai, T., Kiryu, S., Kamioka, H., Ueda, K., Nakano, M., Torisu, Y., Saruta, M., & Tsubota, A. (2026). Clinical usefulness of serum autotaxin levels for predicting decompensation development and prognosis in patients with compensated cirrhosis. PLOS One, 21(4), e0347310. https://doi.org/10.1371/journal.pone.0347310

Vancouver

Saeki C, Oikawa T, Kanai T, Kiryu S, Kamioka H, Ueda K, et al. Clinical usefulness of serum autotaxin levels for predicting decompensation development and prognosis in patients with compensated cirrhosis. PLOS One. 2026;21(4):e0347310. doi:10.1371/journal.pone.0347310

BibTeX
@article{Saeki2026,
  author = {Saeki, Chisato and Oikawa, Tsunekazu and Kanai, Tomoya and Kiryu, Sachie and Kamioka, Hiroshi and Ueda, Kaoru and Nakano, Masanori and Torisu, Yuichi and Saruta, Masayuki and Tsubota, Akihito},
  title = {Clinical usefulness of serum autotaxin levels for predicting decompensation development and prognosis in patients with compensated cirrhosis},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {e0347310},
  doi = {10.1371/journal.pone.0347310}
}
Kostenlos starten →